American Urogyn Society: Mesh Slings Are Safe – Blame Lawyers and Media for Controversy

//American Urogyn Society: Mesh Slings Are Safe – Blame Lawyers and Media for Controversy

American Urogyn Society: Mesh Slings Are Safe – Blame Lawyers and Media for Controversy

AUGS logo2Mesh Medical Device News Desk, January 14, 2014 ~ The jury has been out on the safety of slings to treat stress urinary incontinence (SUI). When the Food and Drug Administration issued its warning to the public in July 2011 (here) it said essentially that the much larger transvaginal mesh used to treat pelvic organ prolapse (POP) carried more risk than benefits and that complications are not rare.

But the FDA left the door open on slings, used to hold up a sagging urethra and prevent the leakage of urine, which affects about one-third of women at some time in her life.

Just this weeks, the American Urogynecologic Society (AUGS) along with the Society of Urodynamics Female Pelvic Medicine & Urogenital Reconstruction (SUFU) have ended the waiting with a Position Statement (here). Slings are safe and effective it says!

It’s estimated up to one-third of women will experience SUI when they laugh, sneeze or cough. While not a painful condition, exercises such as strengthening the pelvic floor may be an effective treatment.

Since the July 2011 FDA warning, lawyers have publicly advertised their services to represent the thousands of women injured by mesh used to treat POP and SUI. The statement goes on to say, “We are concerned that the multimedia attention has resulted in confusion, fear, and an unbalanced negative perception regarding the midurethral sling s a treatment for SUI.”

Blame the media and lawyers.

This perception is not shared by the medical community say the doctors or “An overwhelming majority of women who have been satisfied with the MUS (midurethral sling).”

Both the FDA and these two professional groups acknowledge that the safety of the multi-incisional slings is not well understood in the long term, though a few studies have tried with a limited population. As recently as 2011, researchers stated “there is a need to demonstrate their longevity and safety profiles, particularly in comparison with traditional and established procedures for  pelvic floor repair”  and “Long-term follow-up comparing TVM with accepted ‘gold standard” procedures such as sacral colpopexy would allow accurate assessment of success with appropriate subjective and objective outcome measures and complication rates.”

Justification for the Position Statement

1. Polypropylene (PP) material is safe and effective as a surgical implant.

The statement says PP has been used in surgical procedures for over five decades (as a thread) or as a knitted material (hernia repair).“As a knitted implant for the surgical treatment of SUI, macroporous, monofilament, light weight polypropylene has demonstrated long term durability, safety, and efficacy up to 17 years [8].

(This is a summary. Many women and men with hernia repairs are reporting system reactions to the mesh, which many experts say is not inert in the body)

2. The monofilament polypropylene mesh MUS is the most extensively studied anti-incontinence procedure in history

Midurethral sling (MUS) studies and more than 2,000 publications demonstrate the support the use of MUS as a treatment. A range of studies have consistently demonstrated clinical effectiveness and patient satisfaction. “No other surgical treatment for SUI before or since has been subject to such extensive investigation.”

(Summary of actual statement. SUI slings are not required to undergo clinical trials before they receive FDA approval.)

3. Polypropylene mesh midurethral slings are the standard of care for the surgical treatment of SUI and represent a great advance in the treatment of this condition for our patients.

“Since the publication of numerous level one randomized comparative trials, the MUS has become the most common surgical procedure for the treatment of SUI in the US and the developed world. Full-length midurethral slings, both retropubic and transobturator, have been extensively studied, are safe and effective relative to other treatment options and remain the leading treatment option and current gold standard for stress incontinence surgery [13]. Over 3 million MUS have been placed worldwide and a recent survey indicates that these procedures are used by > 99% of AUGS members [14].”

(Summary of the actual statement which does not mention the thousands of lawsuits filed by some of the women implanted with these slings).

4. The FDA has clearly stated that the polypropylene MUS is safe and effective in the treatment of SUI.

The midurethral sling was not the subject of the 2011 FDA Safety Communication, “Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Vaginal Placement for Pelvic Organ Prolapse.”[3]. In this document, it was explicitly stated: “The FDA continues to evaluate the effects of using surgical mesh for the treatment of SUI and will report about that usage at a later date.” In 2013, the FDA website stated clearly that: “The safety and effectiveness of multi-incision slings is well-established in clinical trials that followed patients for up to one-year.” [5].

(Summary of statement which does not mention the FDA in January 2012 ordered sling makers to conduct 3 years of post-surgical patient monitoring. See story here.)

Conclusion from Position Statement

“The polypropylene midurethral sling has helped millions of women with SUI regain control of their lives by undergoing a simple outpatient procedure that allows them to return to daily life very quickly. With its acknowledged safety and efficacy it has created an environment for a much larger number of women to have access to treatment. In the past, concerns over failure and invasiveness of surgery caused a substantial percent of incontinent women to live without treatment. One of the unintended consequences of this polypropylene mesh controversy has been to keep women from receiving any treatment for SUI. This procedure is probably the most important advancement in the treatment of stress urinary incontinence in the last 50 years and has the full support of our organizations which are dedicated to improving the lives of women with urinary incontinence.”


Learn More:

Mesh Medical Device News Desk, January 2012,  Mesh Makers who Received FDA Letters Requiring Postmarket Surveillance

FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse, July 2011


AUGS & SUFU Position Statement

Nilsson, C.G., et al., Seventeen years’ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J, 2013. 24(8): p. 1265-9.

CG Nilsson, 11-year study on tape procedure for SUI, Intl Urogyn J. 2008,

The ethical issues associated with the introduction of new surgical devices are discussed in a commentary by Ross et al. Ross S, Robert M, Harvey M, Farrell S, Schulz J, Wilkie D, et al. Ethicalissues associated with the introduction of new surgical devices, or just because we can, doesn’t mean we should. J Obstet Gynaecol Can2008;30:508–13

Society of Obstetricians and Gynecologists of Canada


By | 2016-10-11T20:45:06+00:00 January 14th, 2014|Medical News|6 Comments

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.


  1. jade January 15, 2014 at 2:36 pm - Reply

    For anyone of us trying to “swallow” this new AUG position statement – you might want to consider revisiting these stories and this video:

    AUG is the only one “confused” here and their marketing people haven’t learned one thing in all of this. They are still trying to blow smoke! The complications are not rare – AND, they are REAL. To that there is NO counterpoint.

  2. TVTinTN January 15, 2014 at 5:12 pm - Reply

    Tell this to the TVT sling women that have permanent nerve damage from the Mid-Urethra Sling along with autoimmune disorders and other major problems.

    TVT’s are no safer than the POP Slings. It is all poison!

  3. Jaramillo January 21, 2014 at 10:11 am - Reply

    Does it surprise us? Think of the money they stand to loose. Implants, removals, chronic and long term complications, not to mention the possibility of ever being held accountable for the fact that we did not receive informed consent prior to the implant. It’s amazing they did not come across a single erosion when there are so many of us. I question the entire efficacy of this information. Seems the FDA speaks from both ends! They issue warnings and new criteria regarding informing patients, yet they say it’s safe. The majority of physicians do not have to be concerned because they implant and then when there are complications, they diagnose their patients with somatic issues. or drug seekers. They turn them away, ignore the complications and continue to implant and make lots of money. If it is so safe why won’t the companies conduct the studies. Why did the petroleum company indicate a warning on the MDS sheet and why are women and men committing suicide or thinking about it daily. I would love to know how many physicians are advising their wives, mothers, sisters and daughters to have the implant. There has to be male and female physicians that have tvt or hernia repair with mesh. Where are they? We have several stories from nurses that have complications. I wonder why individuals are not writing in regarding the success of their outcomes. I believe there should be victims involved in the studies to monitor efficacy. Perhaps they would consider appointing urologists that do not believe in the mesh to be involved in clinical reviews. For goodness sake we all know that there were researcher’s that reported the products were not safe. Could this be yet another cover up. Those physicians that “do no harm” , Please , Please continue to advocate for us. Your efforts are eternally appreciated. We make minimal progress, yet it gives us hope.

  4. Jaramillo January 21, 2014 at 10:25 am - Reply

    We can all go to their website and contact them, regarding our personal complications. If nothing else their e-mail will be full. I have TVT complications. I filed an initial FDA complication but did not file after my removal surgery or reconstructive surgery. I have gone back to the complaints and did not find a doctor report so perhaps we all need to report surgical intervention due to complications. At a minimum those complaints and need for continual follow up will be there for those individuals that are considering the implant.

  5. Lynn January 25, 2014 at 9:59 pm - Reply

    I e-filed my report with the FDA on 1-4-14. When I recently received a copy of my hospital records, it states that I have a Tension Free Vaginal Tapping by Caldera Medical. The doctor that put the mesh in said that he was putting in a monarc sling (that is by AMS). I do have scars in the groin area from what appears to be a TOT not a TVT. This mesh sling was put in 12-5-11. I have had two (2) partial removals, one on 12-6-12, and one on 5-14-13. I saw Dr. Raz on 12-4-13 for a consultation and am scheduled for surgery at UCLA with Dr. Raz on 6-14-14. I hope someone that is considering mesh will read my story and have a change of heart…..I want to share just a bit of what I put in my FDA complaint…..”I hurt EVERY day ALL DAY LONG; however, I continue to work in pain and support myself. I have used my “off days” built up in my account for doctor’s visits to be off having surgeries to remove this bad mesh. I no longer can work outside in my yard. It hurts to sit or stand for long periods of time. Instead of getting help for my incontinence, I have inherited a life full of pain and suffering for myself. This is a crying shame that a product like this was ever approved to cause pain and mutilation to women. I am totally incontinent, wear the heaviest pad that Poise makes, and have had no sexual relations since this mesh was implanted on 12-5-11. I am 49 years old now…..This is so sad!! How many women have to suffer from these debilitating devices before they are pulled off of the market? What if this was your daughter, your wife, or your mother???? I say this is sheer GREED to market a product that you know in your heart is hurting people!!!!”

  6. carol February 15, 2014 at 1:16 am - Reply

    The FDA doesn’t care about anything but money. I have had this sling I have incontincw worse than before. chronic infections painful sex. I saw the physician 6 months ago that’s when they told me that the sling is only 85% effective. I WISH THEY TOLD ME THAT BEFORE THE SURGERY. I feel so stupid,

Leave A Comment